Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingjun Zhang

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2023
Complement Receptor C3aR1 Contributes to Paclitaxel-Induced Peripheral Neuropathic Pain in Mice and RatsJijun Xu, Ping Huang, Bihua Bie, et al.
Frontiers in Cellular Neuroscience|September 13, 2021
Deletion of <i>C1ql1</i> Causes Hearing Loss and Abnormal Auditory Nerve Fibers in the Mouse CochleaYue Qi, Wei Xiong, Shukui Yu, et al.
Frontiers in Microbiology|October 27, 2025
A brief review of membrane vesicles from <i>Streptococcus mutans</i>Lili Qiu, Qinxia Chen, Gaozhe Zheng, et al.
JCI Insight|November 2, 2023
A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disordersLingjun Zhang, Liping Luo, Jin Y Chen, et al.
International Dental Journal|January 10, 2025
A Pyrroloquinazoline Analogue Regulated Streptococcus mutans and Streptococcus sanguinis Dual-Species BiofilmsKeke Zhang, Mengjia Gao, Gaozhe Zheng, et al.
Journal of Autoimmunity|February 24, 2018
Targeting CD6 for the treatment of experimental autoimmune uveitisLingjun Zhang, Yan Li, Wen Qiu, et al.
JCI Insight|August 11, 2022
CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitisLingjun Zhang, Nozha Borjini, Yu Lun, et al.
Leukemia|August 12, 2023
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphomaNeetha Parameswaran, Liping Luo, Lingjun Zhang, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2023
Complement Receptor C3aR1 Contributes to Paclitaxel-Induced Peripheral Neuropathic Pain in Mice and RatsJijun Xu, Ping Huang, Bihua Bie, et al.
Frontiers in Cellular Neuroscience|September 13, 2021
Deletion of <i>C1ql1</i> Causes Hearing Loss and Abnormal Auditory Nerve Fibers in the Mouse CochleaYue Qi, Wei Xiong, Shukui Yu, et al.
Frontiers in Microbiology|October 27, 2025
A brief review of membrane vesicles from <i>Streptococcus mutans</i>Lili Qiu, Qinxia Chen, Gaozhe Zheng, et al.
JCI Insight|November 2, 2023
A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disordersLingjun Zhang, Liping Luo, Jin Y Chen, et al.
International Dental Journal|January 10, 2025
A Pyrroloquinazoline Analogue Regulated Streptococcus mutans and Streptococcus sanguinis Dual-Species BiofilmsKeke Zhang, Mengjia Gao, Gaozhe Zheng, et al.
Journal of Autoimmunity|February 24, 2018
Targeting CD6 for the treatment of experimental autoimmune uveitisLingjun Zhang, Yan Li, Wen Qiu, et al.
JCI Insight|August 11, 2022
CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitisLingjun Zhang, Nozha Borjini, Yu Lun, et al.
Leukemia|August 12, 2023
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphomaNeetha Parameswaran, Liping Luo, Lingjun Zhang, et al.
Pageof 6